Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Zn-c3
2. 2376146-48-2
3. 9j13xu96z1
4. 1-[(7r)-7-ethyl-7-hydroxy-5,6-dihydrocyclopenta[b]pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one
5. 1-[(7r)-7-ethyl-7-hydroxy-6,7-dihydro-5h-cyclopenta[b]pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-(prop-2-en-1-yl)-1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one
6. 3h-pyrazolo(3,4-d)pyrimidin-3-one, 1-((7r)-7-ethyl-6,7-dihydro-7-hydroxy-5h-cyclopenta(b)pyridin-2-yl)-1,2-dihydro-6-((4-(4-methyl-1-piperazinyl)phenyl)amino)-2-(2-propen-1-yl)-
7. Azenosertib
8. Znc3
9. Unii-9j13xu96z1
10. Schembl21333380
11. Gtpl11731
12. Ex-a6113
13. Nsc837398
14. Nsc-837398
15. Compound 16 [pmid: 34423975]
16. Hy-132295
17. 05j
| Molecular Weight | 526.6 g/mol |
|---|---|
| Molecular Formula | C29H34N8O2 |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Exact Mass | 526.28047236 g/mol |
| Monoisotopic Mass | 526.28047236 g/mol |
| Topological Polar Surface Area | 101 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 875 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A ZN-C3 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ZN-C3, including repackagers and relabelers. The FDA regulates ZN-C3 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ZN-C3 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A ZN-C3 supplier is an individual or a company that provides ZN-C3 active pharmaceutical ingredient (API) or ZN-C3 finished formulations upon request. The ZN-C3 suppliers may include ZN-C3 API manufacturers, exporters, distributors and traders.
ZN-C3 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ZN-C3 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ZN-C3 GMP manufacturer or ZN-C3 GMP API supplier for your needs.
A ZN-C3 CoA (Certificate of Analysis) is a formal document that attests to ZN-C3's compliance with ZN-C3 specifications and serves as a tool for batch-level quality control.
ZN-C3 CoA mostly includes findings from lab analyses of a specific batch. For each ZN-C3 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ZN-C3 may be tested according to a variety of international standards, such as European Pharmacopoeia (ZN-C3 EP), ZN-C3 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ZN-C3 USP).
LOOKING FOR A SUPPLIER?
